Eligard

— THERAPEUTIC CATEGORIES —
  • Prostate and other male cancers

Eligard Generic Name & Formulations

General Description

Leuprolide acetate 7.5mg, 22.5mg, 30mg, 45mg; per inj; ext-rel susp for SC inj.

Pharmacological Class

GnRH analogue.

How Supplied

Single-use kit—1 (with sterile or sterile safety needle)

Manufacturer

Eligard Indications

Indications

Palliative treatment of advanced prostate cancer.

Eligard Dosage and Administration

Adult

Allow product to reach room temperature before using; inject within 30mins of mixing. Use correct formulation. Rotate inj sites. 7.5mg SC once per month; or 22.5mg SC once every 3 months; or 30mg SC once every 4 months; or 45mg SC once every 6 months.

Children

Not established.

Eligard Contraindications

Not Applicable

Eligard Boxed Warnings

Not Applicable

Eligard Warnings/Precautions

Warnings/Precautions

May worsen metastatic vertebral lesions and/or urinary tract obstruction; monitor closely during first few weeks. Increased risk of diabetes, MI, sudden cardiac death, stroke; monitor blood glucose, HbA1c, and for signs/symptoms of CVD during therapy. Risk of QT prolongation in patients with congenital long QT syndrome, CHF, or frequent electrolyte abnormalities. Correct and monitor electrolyte abnormalities; consider monitoring ECGs. Monitor serum testosterone, PSA periodically. Embryo-fetal toxicity. Pregnancy. Nursing mothers: not recommended.

Eligard Pharmacokinetics

See Literature

Eligard Interactions

Interactions

Caution with concomitant drugs known to prolong the QT interval. May interfere with pituitary-gonadal diagnostic tests.

Eligard Adverse Reactions

Adverse Reactions

Malaise, fatigue, hot flashes/sweats, testicular atrophy, local reactions (eg, burning/stinging, pain, erythema, bruising, pruritus); transient worsening of signs/symptoms (eg, bone pain, neuropathy, hematuria, bladder outlet obstruction), spinal cord compression, hyperglycemia, decreased bone density; rare: pituitary apoplexy.

Eligard Clinical Trials

See Literature

Eligard Note

Not Applicable

Eligard Patient Counseling

See Literature